Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Karel Pacak
Affiliation
Eunice Kennedy Shriver National Institute of Child Health and Human Development
ORCID
Career Start Year
1986
Papers
655
H Index
90
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37647861
Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors.
J Clin Endocrinol Metab
2024
36190922
Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.
J Clin Endocrinol Metab
2023
37902037
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
Endocr Relat Cancer
2023
37515400
Paediatric phaeochromocytoma and paraganglioma: A clinical update.
Clin Endocrinol (Oxf)
2023
37156926
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma.
Eur J Nucl Med Mol Imaging
2023
37453673
A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.
Pharmacol Res
2023
37185155
Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma.
Endocr Relat Cancer
2023
36946182
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
J Clin Endocrinol Metab
2023
37450881
Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes.
Endocr Relat Cancer
2023
37342263
Editorial: Pediatric adrenal neoplasms.
Front Endocrinol (Lausanne)
2023
37342258
Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy.
Front Endocrinol (Lausanne)
2023
37011647
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Lancet Diabetes Endocrinol
2023
37011227
Immune Landscape of Pheochromocytoma and Paraganglioma: A Potentially Novel Avenue for Prognostic Reclassification?
J Clin Endocrinol Metab
2023
37339049
A protocol for visualization of murine in situ neurovascular interfaces.
STAR Protoc
2023
37434263
rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.
J Exp Clin Cancer Res
2023
37474439
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
Lancet Digit Health
2023
37030115
The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.
Int Immunopharmacol
2023
36883571
International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes.
Endocr Relat Cancer
2023
36624099
Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
Nat Commun
2023
36854674
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Nat Commun
2023
36538160
Reduced coronary artery luminal area in pheochromocytoma and paraganglioma patients.
J Endocrinol Invest
2023
36733351
Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms.
Front Oncol
2023
36633962
Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.
Endocr Relat Cancer
2023
36759198
The Emergence of Somatostatin Antagonist-Based Theranostics: Paving the Road Toward Another Success?
J Nucl Med
2023
36370152
Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.
Endocrine
2023
36302175
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Clin Cancer Res
2023
34147030
Personalized Management of Pheochromocytoma and Paraganglioma.
Endocr Rev
2022
35536703
Functional Imaging of Neuroendocrine Tumors: Stacking the Odds in a Patient's Favor.
J Clin Endocrinol Metab
2022
35500459
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.
Eur J Cancer
2022
35489703
Somatic Mosaicism of EPAS1 Mutations in Pacak-Zhuang Syndrome.
Endocr Pract
2022
35861986
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.
Eur J Endocrinol
2022
35621181
Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.
Curr Opin Endocrinol Diabetes Obes
2022
35618479
Choice Is Good at Times: The Emergence of [<sup>64</sup>Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [<sup>68</sup>Ga]Ga-DOTATATE.
J Nucl Med
2022
36515265
A remarkable adaptive paradigm of heart performance and protection emerges in response to marked cardiac-specific overexpression of ADCY8.
Elife
2022
36439433
PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma.
Front Oncol
2022
36428741
Preclinical Models of Neuroendocrine Neoplasia.
Cancers (Basel)
2022
36150627
New Biology of Pheochromocytoma and Paraganglioma.
Endocr Pract
2022
36310832
<sup>68</sup>Ga-DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel-Lindau Syndrome.
Nucl Med Mol Imaging
2022
35903274
Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
Front Endocrinol (Lausanne)
2022
36271074
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
Nat Commun
2022
36232321
Chronic Ethanol Consumption Alters Presynaptic Regulation of Dorsal Striatal Dopamine Release in C57BL/6J Mice.
Int J Mol Sci
2022
36353857
A 13-Year-Old Male With Left Eye Swelling.
Pediatrics
2022
36093861
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.
J Bone Miner Res
2022
36010880
Performances of Functional and Anatomic Imaging Modalities in <i>Succinate Dehydrogenase A-</i>Related Metastatic Pheochromocytoma and Paraganglioma.
Cancers (Basel)
2022
35977518
Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer.
Cell Rep
2022
35973976
Targeted Therapies in Pheochromocytoma and Paraganglioma.
J Clin Endocrinol Metab
2022
35158861
New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications.
Cancers (Basel)
2022
35171114
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Endocr Relat Cancer
2022
35324454
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
Endocr Relat Cancer
2022
34792634
Correction to: Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review.
World J Urol
2022
1 - 50 of 655
Column Actions
Search
Recommended Authors
Arman Jahangiri
Hamadan University of Medical Sciences
Career Start Year
2010
Number of shared co-authors
0
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
2
Guido Davidzon
Stanford University
Career Start Year
2005
Number of shared co-authors
0
Suren Soghomonyan
The Ohio State University Wexner Medical Center
Career Start Year
2004
Number of shared co-authors
0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
5
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year
2000
Number of shared co-authors
3
Jennifer A Chan
Dana-Farber Cancer Institute
Career Start Year
1999
Number of shared co-authors
5
Chuong Bui
Nepean Hospital
Career Start Year
1999
Number of shared co-authors
0
Jaishri O Blakeley
Johns Hopkins University
Career Start Year
1998
Number of shared co-authors
3
Bryan Lo
The Ottawa Hospital/University of Ottawa
Career Start Year
1994
Number of shared co-authors
0
Carmel Murone
Olivia Newton-John Cancer Research Institute
Career Start Year
1994
Number of shared co-authors
0
Jian-Qiang Lu
McMaster University
Career Start Year
1991
Number of shared co-authors
0
Mark Gurnell
Wellcome-MRC Institute of Metabolic Science and Addenbrooke's Hospital
Career Start Year
1990
Number of shared co-authors
0
Bruce H Cohen
Akron Children's Hospital
Career Start Year
1988
Number of shared co-authors
2
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1988
Number of shared co-authors
1
Johannes Czernin
university of california los angeles
Career Start Year
1987
Number of shared co-authors
4
David A Eberhard
Lineberger Comprehensive Cancer Center, University of North Carolina
Career Start Year
1987
Number of shared co-authors
2
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year
1986
Number of shared co-authors
1
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1981
Number of shared co-authors
6
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year
1981
Number of shared co-authors
2
Clive S Grant
Inova Health System
Career Start Year
1979
Number of shared co-authors
2
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year
1978
Number of shared co-authors
4
Daniel T O'Connor
Institute for Genomic Medicine, University of California San Diego
Career Start Year
1978
Number of shared co-authors
2
Dana Mathews
University of Texas Southwestern Medical Center
Career Start Year
1977
Number of shared co-authors
0
Anne Jouvet
Groupement Hospitalier EST, Universite de Lyon
Career Start Year
1976
Number of shared co-authors
0
William E Grizzle
University of Alabama at Birmingham
Career Start Year
1974
Number of shared co-authors
3
Michelle F??vre-Montange
INSERM U8, CNRS UMR5292, Universite de Lyon
Career Start Year
1974
Number of shared co-authors
0
David Schiff
University of Virginia School of Medicine
Career Start Year
1966
Number of shared co-authors
3
E. Tessa Hedley-Whyte
Massachusetts General Hospital, Harvard Medical School
Career Start Year
1965
Number of shared co-authors
1
Maria Martinez-Lage
Massachusetts General Hospital
Career Start Year
1960
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Co-authored papers
62
Electron Kebebew
Stanford University School of Medicine
Co-authored papers
38
William Marston Linehan
Co-authored papers
32
Naris Nilubol
Center for Cancer Research
Co-authored papers
30
Stefan R Bornstein
Co-authored papers
26
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers
20
Abdel G Elkahloun
National Human Genome Research Institute
Co-authored papers
15
Anne-Paule Gimenez-Roqueplo
Co-authored papers
15
Dhaval Patel
National Cancer Institute, National Institutes of Health
Co-authored papers
14
Alexander O Vortmeyer
Indiana University School of Medicine
Co-authored papers
14
Nan Qin
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
12
Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
11
Markku Miettinen
National Cancer Institute
Co-authored papers
10
Irina A Lubensky
National Cancer Institute, National Institutes of Health
Co-authored papers
8
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers
8
Uma Shankavaram
Co-authored papers
8
Fred C G J Sweep
Radboud University Medical Centre
Co-authored papers
7
Emily Y Chew
National Eye Institute, National Institutes of Health
Co-authored papers
7
Alberto S Pappo
St Jude Children's Research Hospital
Co-authored papers
6
Nicholas J Patronas
Co-authored papers
5
Lee J Helman
Osteosarcoma Institute
Co-authored papers
5
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers
5
Stephen J Marx
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers
5
Peter J Munson
and Blood Institute, National Institutes of Health
Co-authored papers
5
Jonathan K Killian
From Foundation Medicine
Co-authored papers
4
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
4
Aguirre A de Cubas
Co-authored papers
4
Brian Shuch
University of California los angeles
Co-authored papers
4
Jennifer J Barb
Clinical Center, National Institutes of Health
Co-authored papers
3
Dale O Kiesewetter
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers
3
1 - 30